Sleeping Sickness at the Crossroads

Overview

Journal Trop Med Infect Dis

Specialty Infectious Diseases

Date 2020 Apr 12

PMID 32276514

Citations 2

Authors

Christian Burri

Affiliations

Soon will be listed here.

Abstract

Human African trypanosomiasis (HAT; sleeping sickness) is a disease with truly historic dimensions [...].

Citing Articles

A structural classification of the variant surface glycoproteins of the African trypanosome.

dakovic S, Zeelen J, Gkeka A, Chandra M, van Straaten M, Foti K PLoS Negl Trop Dis. 2023; 17(9):e0011621.

PMID: 37656766 PMC: 10501684. DOI: 10.1371/journal.pntd.0011621.

Analyzing editosome function in high-throughput.

Del Campo C, Leeder W, Reissig P, Goringer H Nucleic Acids Res. 2020; 48(17):e99.

PMID: 32756897 PMC: 7515698. DOI: 10.1093/nar/gkaa658.

References

Pandey A, Atkins K, Bucheton B, Camara M, Aksoy S, Galvani A . Evaluating long-term effectiveness of sleeping sickness control measures in Guinea. Parasit Vectors. 2015; 8:550. PMC: 4618537. DOI: 10.1186/s13071-015-1121-x. View

Brun R, Balmer O . New developments in human African trypanosomiasis. Curr Opin Infect Dis. 2006; 19(5):415-20. DOI: 10.1097/01.qco.0000244045.93016.b1. View

Caljon G, Van Reet N, De Trez C, Vermeersch M, Perez-Morga D, Van Den Abbeele J . The Dermis as a Delivery Site of Trypanosoma brucei for Tsetse Flies. PLoS Pathog. 2016; 12(7):e1005744. PMC: 4956260. DOI: 10.1371/journal.ppat.1005744. View

Bacchi C, Nathan H, Clarkson Jr A, Bienen E, Bitonti A, McCann P . Effects of the ornithine decarboxylase inhibitors DL-alpha-difluoromethylornithine and alpha-monofluoromethyldehydroornithine methyl ester alone and in combination with suramin against Trypanosoma brucei brucei central nervous system models. Am J Trop Med Hyg. 1987; 36(1):46-52. DOI: 10.4269/ajtmh.1987.36.46. View

Franco J, Simarro P, Diarra A, Jannin J . Epidemiology of human African trypanosomiasis. Clin Epidemiol. 2014; 6:257-75. PMC: 4130665. DOI: 10.2147/CLEP.S39728. View

Capewell P, Cren-Travaille C, Marchesi F, Johnston P, Clucas C, Benson R . The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes. Elife. 2016; 5. PMC: 5065312. DOI: 10.7554/eLife.17716. View

Dama E, Camara O, Kaba D, Koffi M, Camara M, Compaore C . Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis. Parasite. 2019; 26:68. PMC: 6873819. DOI: 10.1051/parasite/2019066. View

Jannin J . Sleeping sickness--a growing problem?. BMJ. 2005; 331(7527):1242. PMC: 1289321. DOI: 10.1136/bmj.331.7527.1242. View

Jannin J, Louis F, Lucas P, Simarro P . [Control of human African trypanosomiasis: back to square one]. Med Trop (Mars). 2002; 61(4-5):437-40. View

10.

Simarro P, Franco J, Diarra A, Ruiz Postigo J, Jannin J . Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology. 2012; 139(7):842-6. DOI: 10.1017/S0031182012000169. View

11.

Bendiner E . Louise Pearce: a 'magic bullet' for African sleeping sickness. Hosp Pract (Off Ed). 1992; 27(1):207-15, 218, 221. DOI: 10.1080/21548331.1992.11705350. View

12.

Maudlin I . African trypanosomiasis. Ann Trop Med Parasitol. 2007; 100(8):679-701. DOI: 10.1179/136485906X112211. View

13.

Falisse J, Mwamba-Miaka E, Mpanya A . Whose Elimination? Frontline Workers' Perspectives on the Elimination of the Human African Trypanosomiasis and Its Anticipated Consequences. Trop Med Infect Dis. 2020; 5(1). PMC: 7157216. DOI: 10.3390/tropicalmed5010006. View

14.

Kuboki N, Inoue N, Sakurai T, Di Cello F, Grab D, Suzuki H . Loop-mediated isothermal amplification for detection of African trypanosomes. J Clin Microbiol. 2003; 41(12):5517-24. PMC: 308967. DOI: 10.1128/JCM.41.12.5517-5524.2003. View

15.

Ndeffo-Mbah M, Pandey A, Atkins K, Aksoy S, Galvani A . The impact of vector migration on the effectiveness of strategies to control gambiense human African trypanosomiasis. PLoS Negl Trop Dis. 2019; 13(12):e0007903. PMC: 6894748. DOI: 10.1371/journal.pntd.0007903. View

16.

Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U . Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet. 2009; 374(9683):56-64. DOI: 10.1016/S0140-6736(09)61117-X. View

17.

Lejon V, Buscher P, Nzoumbou-Boko R, Bossard G, Jamonneau V, Bucheton B . The separation of trypanosomes from blood by anion exchange chromatography: From Sheila Lanham's discovery 50 years ago to a gold standard for sleeping sickness diagnosis. PLoS Negl Trop Dis. 2019; 13(2):e0007051. PMC: 6394898. DOI: 10.1371/journal.pntd.0007051. View

18.

Buscher P, Mertens P, Leclipteux T, Gilleman Q, Jacquet D, Mumba-Ngoyi D . Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study. Lancet Glob Health. 2014; 2(6):e359-63. DOI: 10.1016/S2214-109X(14)70203-7. View

19.

Steverding D . The development of drugs for treatment of sleeping sickness: a historical review. Parasit Vectors. 2010; 3(1):15. PMC: 2848007. DOI: 10.1186/1756-3305-3-15. View

20.

Franco J, Cecchi G, Priotto G, Paone M, Diarra A, Grout L . Monitoring the elimination of human African trypanosomiasis: Update to 2016. PLoS Negl Trop Dis. 2018; 12(12):e0006890. PMC: 6283345. DOI: 10.1371/journal.pntd.0006890. View